NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 53 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -37.5% | 23,514 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $24,000 | -78.8% | 23,514 | 0.0% | 0.00% | -77.8% |
| Q1 2022 | $113,000 | 0.0% | 23,514 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $113,000 | -33.9% | 23,514 | -0.3% | 0.01% | -40.0% |
| Q3 2021 | $171,000 | -21.2% | 23,595 | +0.3% | 0.02% | -21.1% |
| Q2 2021 | $217,000 | -24.9% | 23,514 | 0.0% | 0.02% | -32.1% |
| Q1 2021 | $289,000 | -22.5% | 23,514 | -11.1% | 0.03% | -30.0% |
| Q4 2020 | $373,000 | +32.3% | 26,441 | +12.4% | 0.04% | +11.1% |
| Q3 2020 | $282,000 | – | 23,514 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 199,000 | $205,000 | 0.29% |
| Opaleye Management Inc. | 610,000 | $628,000 | 0.28% |
| Redmile Group, LLC | 3,436,935 | $3,540,000 | 0.14% |
| Kynam Capital Management, LP | 124,701 | $128,000 | 0.03% |
| Baker Brothers Advisors | 3,821,740 | $3,936,000 | 0.02% |
| Sio Capital Management, LLC | 38,312 | $39,000 | 0.02% |
| Candriam S.C.A. | 781,577 | $805,000 | 0.01% |
| Highland Private Wealth Management | 46,999 | $48,000 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $49,000 | 0.01% |
| Point72 Asset Management, L.P. | 1,437,417 | $1,481,000 | 0.01% |